A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis. AJPS [Internet]. 2010 Jun. 1 [cited 2025 Apr. 19];7(1):90-105. Available from: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/321